BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...

Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...

Penumbra has issued an urgent recall of all configurations of the Penumbra JET 7 Reperfusion Catheter With Xtra Flex Technology (JET 7 Xtra Flex), owing to the risk for "unexpected death or serious ...

ALAMEDA, Calif., Dec. 15, 2020 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it is voluntarily recalling all configurations of the Penumbra JET® 7 Reperfusion Catheter with Xtra Flex ...

The FDA says it received over 200 reports associated with Penumbra’s catheter, including ‘deaths, serious injuries, and malfunctions.’ Penumbra (PEN) shares slumped Wednesday after the medical device ...

Penumbra, Inc. PEN recently announced the launch of JET 7 and JET D Reperfusion Catheters in the United States. Notably, these reperfusion catheters have been powered by the Penumbra ENGINE aspiration ...

Penumbra, a company famous for its suction-based stroke clot removal devices, is releasing what it says is its “most advanced technology,” the Penumbra JET 7 and Penumbra JET D Reperfusion Catheters.

Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, announced that its RED ® Reperfusion Catheters have secured CE Mark (Conformité Européenne) and are now ...

December 9, 2010 — A recall of some Penumbra Reperfusion Catheters 032, catalogue number PSC032, produced from lot F15020, has now been deemed a Class I recall, according to an alert from MedWatch, ...

About the ACE68 Reperfusion Catheter and the Penumbra System The Penumbra System with the ACE68 Reperfusion Catheter is indicated for use in the revascularization of patients with acute ischemic ...